# Clinical Trial to Evaluate the Drug Drug Interaction of CKD-501 and D308

> **NCT03616392** · PHASE1 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 41 (actual)

## Conditions studied

- Diabetes Mellitus, Type II

## Interventions

- **DRUG:** D308, CKD-501

## Key facts

- **NCT ID:** NCT03616392
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-25
- **Primary completion:** 2018-09-17
- **Final completion:** 2018-11-13
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2018-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03616392

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03616392, "Clinical Trial to Evaluate the Drug Drug Interaction of CKD-501 and D308". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT03616392. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*